← Back to Search

Double dose of Gadopentetate dimeglumine for Meniere's Disease

N/A
Waitlist Available
Led By Patricia Hudgins, MD
Research Sponsored by Emory University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 hours after intravenous contrast injection
Awards & highlights
Approved for 5 Other Conditions
All Individual Drugs Already Approved
No Placebo-Only Group

Summary

The purpose of this research study is to see if magnetic resonance imaging (MRI) with a double dose of contrast, or dye, and delayed imaging with MRI can help to diagnose Meniere Disease.

Eligible Conditions
  • Meniere's Disease

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 hours after intravenous contrast injection
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 hours after intravenous contrast injection for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Grade of endolymphatic hydrops (EH) in the cochlea and vestibule

Awards & Highlights

Approved for 5 Other Conditions
This treatment demonstrated efficacy for 5 other conditions.
All Individual Drugs Already Approved
Therapies where all constituent drugs have already been approved are likely to have better-understood side effect profiles.
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Double dose of Gadopentetate dimeglumineExperimental Treatment1 Intervention
Subjects with a clinical diagnosis of unilateral Meniere Disease (MD) will undergo 3T MR imaging with a double dose of intravenous (IV) gadolinium contrast injection: 0.2 mmol/kg of Gd-DTPA (Magnevist)
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Gadopentetic acid
FDA approved

Find a Location

Who is running the clinical trial?

Emory UniversityLead Sponsor
1,701 Previous Clinical Trials
2,604,731 Total Patients Enrolled
Patricia Hudgins, MDPrincipal InvestigatorEmory University
~0 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top